Akron Formulations India Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1985.
1985 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Akron Formulations India Private Limited

Akron Formulations India Private Limited, a active private limited company, was established on 05 August 1985 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1985PTC005701. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹14.00 Cr and a paid-up capital of ₹13.98 Cr.

Formerly known as Hightech Pharmaceuticals Pvt Ltd. It upholds a compliant status. Employing 91 professional, Its leadership includes Kumaraswamy Reddy Maruri (Director), Maruri Leelavathi (Director), Satyanarayana Reddy (Director). Past directors included Penumatsa Sarala Devi, Sulochana Srinivasan, Umadevi Chava. It holds ₹39.01 Cr open charges and ₹34.92 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at #134-B, Ida Bollaram Jinnaram Mandal, Hyderabad, Telangana, 502325.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1985PTC005701

  • Registration Number

    005701

  • Incorporation Date

    05 August 1985

  • Authorized Capital

    ₹14.00 Cr

  • Paid-Up Capital

    ₹13.98 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 14.00 Cr
  • Paid Up Capital ₹ 13.98 Cr
  • Company Age 40 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 39.01 Cr
  • Satisfied Charges ₹ 34.92 Cr
  • Revenue Growth **** -44.56%
  • Profit Growth **** -92.67%
  • Ebitda **** -34.02%
  • Net Worth 0.67%
  • Total Assets -11.49%
Company report

Akron Formulations India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Akron Formulations India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Akron Formulations India Private Limited?
Current Directors
Name Designation Appointment Date Status
Kumaraswamy Reddy Maruri Director 27 Feb 2023 Current
Maruri Leelavathi Director 12 Mar 2024 Current
Satyanarayana Reddy Director 27 Feb 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Aug 2021 Past
Pramod Abcsdd Director 08 Sep 2012 Past
Pramod Abcsdd Additional Director 03 Nov 2022 Past
Pramod Abcsdd Director 03 Nov 2022 Past
Pramod Abcsdd Director 31 Mar 2023 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Akron Formulations India.

Akron Formulations India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.56% decrease. The company also saw a substantial fall in profitability, with a 92.67% decrease in profit. The company's net worth moved up by a moderate rise of 0.67%.

Akron Formulations India revenue growth over time
Akron Formulations India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -44.56%
*******
*******
*******
*******
Revenue from Operations
*******
 -44.63%
*******
*******
*******
*******
Total Assets
*******
 -11.49%
*******
*******
*******
*******
Profit or Loss
*******
 -92.67%
*******
*******
*******
*******
Net Worth
*******
 0.67%
*******
*******
*******
*******
EBITDA
*******
 -34.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Akron Formulations India?

In 2024, Akron Formulations India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹390,100,000.00

Satisfied Charges

₹349,156,250.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 25.00 Cr
  • Indian Bank : 14.01 Cr
Latest Charge Details
Date Lender Amount Status
01 Dec 2025 Indian Bank ₹14.01 Cr Open
10 Jul 2014 Axis Bank Limited ₹25.00 Cr Open
27 May 2021 Sidbi ₹2.00 Cr Satisfied
26 Nov 2020 Sidbi ₹2.52 Cr Satisfied
29 Jul 2019 Hdfc Bank Limited ₹7.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Akron Formulations India?

Akron Formulations India has a workforce of 91 employees as of Apr 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Akron Formulations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akron Formulations India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Akron Formulations India
Recent Activity within the Organization
  • Charges

    The activity A charge with Indian Bank amounted to Rs. 14.01 Cr with Charge ID 101203451 was registered on 01 Dec 2025. was completed.

  • Annual General Meeting

    Akron Formulations India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Akron Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 10 Jul 2014 with Charge ID 10509274 was modified on 30 Sep 2024. was documented.

  • Director Appointment

    Progress on Maruri Leelavathi was appointed as a Director was appointed as a Director on 12 Mar 2024 & has been associated with this company since 1 year 11 months . was documented.

  • Director Appointment

    Progress on Kapil Mundhada was appointed as a Company Secretary was appointed as a Company Secretary on 06 Mar 2024 & has been associated with this company since 1 year 11 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Akron Formulations India Private Limited?

The CIN of Akron Formulations India Private Limited is U24239TG1985PTC005701.

Where is Akron Formulations India Private Limited headquartered?

Akron Formulations India Private Limited is headquartered at #134-B, Ida Bollaram Jinnaram Mandal, Hyderabad, Telangana, 502325.

When was Akron Formulations India Private Limited incorporated?

Akron Formulations India Private Limited was incorporated on 05 August 1985.

Who are the current directors of Akron Formulations India Private Limited?

The current directors of Akron Formulations India Private Limited are

What is the primary industry of Akron Formulations India Private Limited?

The primary industry of Akron Formulations India Private Limited is Manufacturing.

Is Akron Formulations India Private Limited a listed company?

Akron Formulations India Private Limited is unlisted.

What is the capital structure of Akron Formulations India Private Limited?

The authorized capital of Akron Formulations India Private Limited is ₹14.00 Cr, and the paid-up capital is ₹13.98 Cr.

What is the compliance status of Akron Formulations India Private Limited?

The compliance status of Akron Formulations India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available